Dirk Scharn
Impact in
-
- Protein Degradation and Inhibitors
- Protein Kinase Regulation and GTPase Signaling
- Chemical Synthesis and Analysis
- Genomics and Chromatin Dynamics
-
- Lung Cancer Treatments and Mutations
Papers in
- Genetics 4
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 4
-
- Mast cells and histamine 2
- Co-authors
- Elsa Locardi (5 shared papers)Karsten Schnatbaum (5 shared papers)Uwe Richter (5 shared papers)Thomas Polakowski (1 shared paper)Heiko Hawlisch (1 shared paper)Jochen Knolle (1 shared paper)Daniel Gerlach (1 shared paper)Johannes Popow (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of Medicinal Chemistry (4 papers)Molecular Cancer Therapeutics (1 paper)Nature Cancer (1 paper)Cancer Discovery (1 paper)
- Partner nations
- AustriaUnited StatesNetherlands
In The Last Decade
Dirk Scharn
16 papers receiving 636 citations
Peers
Comparison fields: 5 of 56
- Molecular Biology 295
- Pulmonary and Respiratory Medicine 128
- Computational Theory and Mathematics 66
- Immunology and Allergy 15
- Pathology and Forensic Medicine 42
Countries citing papers authored by Dirk Scharn
This map shows the geographic impact of Dirk Scharn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Scharn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Scharn more than expected).
Fields of papers citing papers by Dirk Scharn
This network shows the impact of papers produced by Dirk Scharn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Scharn. The network helps show where Dirk Scharn may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Scharn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 172 | |
| 2 | 2019 | 130 | |
| 3 | 2018 | 70 | |
| 4 | 2018 | 50 | |
| 5 | 2020 | 49 | |
| 6 | 2006 | 39 | |
| 7 | 2022 | 38 | |
| 8 | 2024 | 38 | |
| 9 | 2009 | 24 | |
| 10 | 2012 | 15 | |
| 11 | 2013 | 10 | |
| 12 | 2009 | 8 | |
| 13 | 2009 | 8 | |
| 14 | 2009 | 7 | |
| 15 | 2009 | 5 | |
| 16 | 2009 | 4 |
About Dirk Scharn
Dirk Scharn is a scholar working on Genetics, Immunology, Immunology and Allergy, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 16 papers that have together received 667 indexed citations. Recurring topics across this work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Lung Cancer Treatments and Mutations (3 papers), Protein Degradation and Inhibitors (2 papers), Cell Adhesion Molecules Research (2 papers), Mast cells and histamine (2 papers), Receptor Mechanisms and Signaling (1 paper), Synthesis and biological activity (1 paper) and Protein Kinase Regulation and GTPase Signaling (1 paper). The work is most often cited by research in Molecular Biology (295 citations), Pulmonary and Respiratory Medicine (128 citations), Computational Theory and Mathematics (66 citations), Immunology and Allergy (15 citations) and Pathology and Forensic Medicine (42 citations). Dirk Scharn has collaborated with scholars based in Austria, United States and Netherlands. Frequent co-authors include Elsa Locardi, Karsten Schnatbaum, Uwe Richter, Thomas Polakowski, Heiko Hawlisch, Jochen Knolle, Daniel Gerlach, Johannes Popow, Thomas Gerstberger and Fabio Savarese. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Molecular Cancer Therapeutics, Nature Cancer and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.